Moreover, high gene expression of PLA2G4A has been correlated with poor patient outcomes, e.g., relapse, development of metastasis and lower survival, in cancers of lung, liver, and breast, glioblastoma, and multiple myeloma [18,19,20,21,22]. The gene discussed is PLA2G4A; the disease is AL amyloidosis.